AHANeurology2021

AHA/ASA Guideline for the Prevention of Stroke in Patients with Stroke and TIA 2021

Published by American Heart Association · 82 pages · Class I–III

21 daysDAPT duration

<130/80BP Target

Class IStatin

Summary

Free preview

Focused update on secondary stroke prevention. Dual antiplatelet therapy (aspirin + clopidogrel or ticagrelor) for 21 days following minor stroke/high-risk TIA is Class I. Intracranial stenting not recommended for symptomatic patients on maximal medical therapy.

StrokeTIASecondary preventionDAPTAnticoagulationCarotid endarterectomy

Key Recommendations

Evidence Grading & Drug Doses

What's New vs Previous Version

Implementation & Clinical Pearls

Full guideline access requires an account

Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.

Full guideline text with all recommendations

Evidence grades (Class I/II/III, Level A/B/C)

AI-generated summary and clinical pearls

Auto-logged as CPD/CME activity

Create Free Account — Instant Access Sign In

Free plan includes 10 guideline reads per day · No credit card required

Loading your page…